As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.
As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator, write Loic Plantevin, Christoph Schlegel and Maria Gordian.